These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15050146

  • 1. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.
    Garcia M, Weppler D, Mittal N, Nishida S, Kato T, Tzakis A, Ruiz P.
    Transplant Proc; 2004 Mar; 36(2):323-4. PubMed ID: 15050146
    [Abstract] [Full Text] [Related]

  • 2. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
    Zanfi C, Lauro A, Cescon M, Dazzi A, Ercolani G, Grazi GL, Zanello M, Vivarelli M, Del Gaudio M, Ravaioli M, Cucchetti A, Vetrone G, Tuci F, Di Gioia P, Lazzarotto T, D'Errico A, Bagni A, Faenza S, Siniscalchi A, Pironi L, Pinna AD.
    Transplant Proc; 2010 Mar; 42(1):35-8. PubMed ID: 20172276
    [Abstract] [Full Text] [Related]

  • 3. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period.
    Lauro A, Amaduzzi A, Dazzi A, Ercolani G, Zanfi C, Golfieri L, Grazi GL, Vivarelli M, Cescon M, Varotti G, Del Gaudio M, Ravaioli M, Siniscalchi A, Faenza S, D'Errico A, Di Simone M, Pironi L, Pinna AD.
    Dig Liver Dis; 2007 Mar; 39(3):253-6. PubMed ID: 17275428
    [Abstract] [Full Text] [Related]

  • 4. Lymphoplasmacytic hyperplasia (possibly pre-PTLD) has varied expression and appearance in intestinal transplant recipients receiving Campath immunosuppression.
    Ruiz P, Soares MF, Garcia M, Nicolas M, Kato T, Mittal N, Nishida S, Levi D, Selvaggi G, Madariaga J, Tzakis A.
    Transplant Proc; 2004 Mar; 36(2):386-7. PubMed ID: 15050168
    [Abstract] [Full Text] [Related]

  • 5. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
    Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N, Toit C, Abrahams L, Thomas V, Bunjes D, Duncker C, Wiesneth M, Selleslag D, Hidajat M, Starobinski M, Bird P, Waldmann H.
    Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
    [Abstract] [Full Text] [Related]

  • 6. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.
    Tzakis AG, Kato T, Nishida S, Levi DM, Madariaga JR, Nery JR, Mittal N, Regev A, Cantwell P, Gyamfi A, Weppler D, Miller J, Tryphonopoulos P, Ruiz P.
    Transplantation; 2003 Apr 27; 75(8):1227-31. PubMed ID: 12717207
    [Abstract] [Full Text] [Related]

  • 7. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
    Zhang PL, Malek SK, Blasick TM, Pennington JR, Masker KK, Lun M, Potdar S.
    Ann Clin Lab Sci; 2007 Apr 27; 37(2):121-6. PubMed ID: 17522366
    [Abstract] [Full Text] [Related]

  • 8. The impact of Campath 1H induction in adult liver allotransplantation.
    Tryphonopoulos P, Madariaga JR, Kato T, Nishida S, Levi DM, Moon J, Selvaggi G, De Faria W, Regev A, Bejarano P, Khaled A, Safdar K, Esquenazi V, Weppler D, Yoshida H, Ruiz P, Miller J, Tzakis AG.
    Transplant Proc; 2005 Mar 27; 37(2):1203-4. PubMed ID: 15848669
    [Abstract] [Full Text] [Related]

  • 9. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients.
    Nishida S, Levi DM, Moon JI, Madariaga JR, Kato T, Selvaggi G, Tryphonopoulos P, DeFaria W, Santiago S, Gaynor J, Weppler D, Martinez E, Ruiz P, Tzakis AG.
    Transplant Proc; 2006 Mar 27; 38(6):1747-9. PubMed ID: 16908270
    [Abstract] [Full Text] [Related]

  • 10. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
    Muñoz AS, Cabanayan-Casasola CB, Danguilan RA, Padua FB, Ona ET.
    Transplant Proc; 2008 Sep 27; 40(7):2230-3. PubMed ID: 18790200
    [Abstract] [Full Text] [Related]

  • 11. Campath-1H in renal transplantation: The University of Wisconsin experience.
    Knechtle SJ, Fernandez LA, Pirsch JD, Becker BN, Chin LT, Becker YT, Odorico JS, D'alessandro AM, Sollinger HW.
    Surgery; 2004 Oct 27; 136(4):754-60. PubMed ID: 15467659
    [Abstract] [Full Text] [Related]

  • 12. Intestinal and multivisceral transplantation immunosuppression protocols--literature review.
    Trevizol AP, David AI, Dias ER, Mantovani D, Pécora R, D'Albuquerque LA.
    Transplant Proc; 2012 Oct 27; 44(8):2445-8. PubMed ID: 23026616
    [Abstract] [Full Text] [Related]

  • 13. Campath-1H in intestinal and multivisceral transplantation: preliminary data.
    Tzakis AG, Kato T, Nishida S, Levi D, Madariaga J, De Faria W, Nery J, Neff G, Kirk AD, Ruiz P.
    Transplant Proc; 2002 May 27; 34(3):937. PubMed ID: 12034248
    [No Abstract] [Full Text] [Related]

  • 14. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
    Trzonkowski P, Zilvetti M, Friend P, Wood KJ.
    Transplantation; 2006 Nov 27; 82(10):1342-51. PubMed ID: 17130784
    [Abstract] [Full Text] [Related]

  • 15. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J.
    Clin Transpl; 2009 Nov 27; ():83-101. PubMed ID: 20524278
    [Abstract] [Full Text] [Related]

  • 16. Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients.
    Csapo Z, Benavides-Viveros C, Podder H, Pollard V, Kahan BD.
    Transplant Proc; 2005 Jun 27; 37(5):2032-6. PubMed ID: 15964331
    [Abstract] [Full Text] [Related]

  • 17. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation.
    Tzakis AG, Kato T, Nishida S, Levi DM, Tryphonopoulos P, Madariaga JR, De Faria W, Nery JR, Regev A, Vianna R, Miller J, Esquenazi V, Weppler D, Ruiz P.
    Transplantation; 2003 May 15; 75(9):1512-7. PubMed ID: 12792506
    [Abstract] [Full Text] [Related]

  • 18. Campath induction for kidney transplantation: report of 297 cases.
    Ortiz J, Palma-Vargas J, Wright F, Bingaman A, Agha I, Rosenblatt S, Foster P.
    Transplantation; 2008 Jun 15; 85(11):1550-6. PubMed ID: 18551058
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary experience with Campath 1H induction combined with low-dose monotherapy of tacrolimus in small bowel transplantation].
    Li YX, Li N, Ni XD, Li YS, Li M, Shen J, Li JS.
    Zhonghua Wai Ke Za Zhi; 2009 Jun 01; 47(11):810-3. PubMed ID: 19961008
    [Abstract] [Full Text] [Related]

  • 20. Intestinal and multivisceral transplantation in children.
    Kato T, Tzakis AG, Selvaggi G, Gaynor JJ, David AI, Bussotti A, Moon JI, Ueno T, DeFaria W, Santiago S, Levi DM, Nishida S, Velasco ML, McLaughlin G, Hernandez E, Thompson JF, Cantwell P, Holliday N, Livingstone AS, Ruiz P.
    Ann Surg; 2006 Jun 01; 243(6):756-64; discussion 764-6. PubMed ID: 16772779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.